The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Antero Resources LLC | Common | 03674X106 | 363 | 131,895 | SH | SOLE | 131,895 | 0 | 0 | ||
Arvinas, Inc. | Common | 04335A105 | 393 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | ||
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 290 | 9,581 | SH | SOLE | 9,581 | 0 | 0 | ||
Castlight Health, Inc. | Common CLB | 14862Q100 | 394 | 349,070 | SH | SOLE | 349,070 | 0 | 0 | ||
Constellation Pharmaceuticals, Inc. | Common | 210373106 | 1,005 | 49,614 | SH | SOLE | 49,614 | 0 | 0 | ||
Crispr Therapeutics AG | Namen AKT | 000000000 | 1,793 | 21,439 | SH | SOLE | 21,439 | 0 | 0 | ||
Cytomx Therapeutics, Inc. | Common | 23284F105 | 527 | 79,193 | SH | SOLE | 79,193 | 0 | 0 | ||
Exagen, Inc. | Common | 30068X103 | 282 | 25,982 | SH | SOLE | 25,982 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 295 | 24,686 | SH | SOLE | 24,686 | 0 | 0 | ||
Hallador Energy Resources, Inc. | Common | 40609P105 | 9 | 14,270 | SH | SOLE | 14,270 | 0 | 0 | ||
IVERIC Bio, Inc. | Common | 46583P102 | 2,497 | 442,810 | SH | SOLE | 442,810 | 0 | 0 | ||
LendingClub Corp. | Common | 52603A208 | 2,418 | 513,440 | SH | SOLE | 513,440 | 0 | 0 | ||
Lyft, Inc. | Common CL A | 55087P104 | 710 | 25,785 | SH | SOLE | 25,785 | 0 | 0 | ||
NextCure, Inc. | Common | 65343E108 | 88 | 10,044 | SH | SOLE | 10,044 | 0 | 0 | ||
Nutanix, Inc. | Common CL A | 67059N108 | 2,352 | 106,049 | SH | SOLE | 106,049 | 0 | 0 | ||
1Life Healthcare, Inc. | Common | 68269G107 | 9,968 | 351,480 | SH | SOLE | 351,480 | 0 | 0 | ||
PagerDuty, Inc. | Common | 69553P100 | 1,841 | 67,891 | SH | SOLE | 67,891 | 0 | 0 | ||
Phreesia, Inc. | Common | 71944F106 | 789 | 24,562 | SH | SOLE | 24,562 | 0 | 0 | ||
PluralSight, Inc. | Common CL A | 72941B106 | 3,029 | 176,807 | SH | SOLE | 176,807 | 0 | 0 | ||
Progyny, Inc. | Common | 74340E103 | 2,577 | 87,574 | SH | SOLE | 87,574 | 0 | 0 | ||
Proteostasis Therapeutics, Inc. | Common | 74373B109 | 485 | 440,627 | SH | SOLE | 440,627 | 0 | 0 | ||
Ramaco Resources, Inc. | Common | 75134P303 | 52 | 14,951 | SH | SOLE | 14,951 | 0 | 0 | ||
The RealReal, Inc. | Common | 88339P101 | 106 | 7,300 | SH | SOLE | 7,300 | 0 | 0 | ||
Spark Networks SE | Sponsored ADR | 846517100 | 2,458 | 502,576 | SH | SOLE | 502,576 | 0 | 0 | ||
Stitchfix, Inc. | Common CL A | 860897107 | 1,806 | 66,571 | SH | SOLE | 66,571 | 0 | 0 | ||
TelaDoc Health, Inc. | Common | 87918A105 | 11,169 | 50,943 | SH | SOLE | 50,493 | 0 | 0 | ||
Trevena, Inc. | Common | 89532E109 | 699 | 233,850 | SH | SOLE | 233,850 | 0 | 0 | ||
Veracyte, Inc. | Common | 92337F107 | 766 | 23,591 | SH | SOLE | 23,591 | 0 | 0 | ||
Yext, Inc. | Common | 98585N106 | 1,748 | 115,147 | SH | SOLE | 115,147 | 0 | 0 | ||
Zuora, Inc. | Common | 98983V106 | 1,695 | 163,894 | SH | SOLE | 163,894 | 0 | 0 | ||
Axcella Health, Inc. | Common | 05454B105 | 12,973 | 2,807,981 | SH | SOLE | 2,807,981 | 0 | 0 | ||
Evelo Biosciences, Inc. | Common | 299734103 | 16,145 | 3,063,505 | SH | SOLE | 3,063,505 | 0 | 0 | ||
Cornerstone OnDemand Inc. | Common | 483347100 | 3,134 | 86,195 | SH | SOLE | 86,195 | 0 | 0 | ||
Rubius Therapeutics, Inc. | Common | 78116T103 | 4,944 | 986,878 | SH | SOLE | 986,878 | 0 | 0 | ||
Kaleido BioSciences, Inc. | Common | 483347100 | 20,301 | 1,833,832 | SH | SOLE | 1,833,832 | 0 | 0 | ||
Solarwinds Corp. | Common | 83417Q105 | 160,133 | 7,872,801 | SH | SOLE | 7,872,801 | 0 | 0 |